Maia Biotechnology (MAIA): Director bought ~$16K
Stan Smith, Director at Maia Biotechnology, bought ~$16K of Maia Biotechnology shares.
- ~$16K
- Approx. value · 15K sh @ $1.04
- 1.36M
- Holds after · shares reported
- Traded
- Nov 26, 2025
- Filed
- Dec 1, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Sep 19, 2022InsiderDirector purchased ~$10K of MAIA shares in the open market
- Sep 29, 2025Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
- Oct 13, 2025Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
- Nov 21, 2025Insider · First buy since 2023CEO purchased ~$1.7K of MAIA shares in the open market
- Nov 24, 2025Insider · 2 peopleInsiders: 2 purchases (~$20K)
- Nov 25, 2025Insider · 3 peopleInsiders: 3 purchases (~$35K)
- Nov 26, 2025 · this disclosureInsider · 3 insiders in a week, 6th time since 2022Director purchased ~$16K of MAIA shares in the open market
What came next
- Nov 26, 2025Insider · 2 peopleInsiders: 2 purchases (~$45K)
- Nov 28, 2025Insider · 2 peopleInsiders: 2 purchases (~$77K)
- Dec 5, 2025Insider · 1 personInsiders: 3 purchases (~$16K)
- Dec 16, 2025Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
- Dec 22, 2025Insider · 3 peopleInsiders: 3 purchases (~$220K)
- Mar 2, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Maia Biotechnology
For Maia Biotechnology, OQRO holds 7 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MAIA page.
Other recent filings by Stan Smith, Director
- SEC Form 4 at Maia Biotechnology (MAIA)Nov 17, 2026
- SEC Form 4 at Maia Biotechnology (MAIA)Nov 17, 2026
- SEC Form 4 at Maia Biotechnology (MAIA)Jun 2, 2026
- SEC Form 4 at Maia Biotechnology (MAIA)Jan 12, 2026
- SEC Form 4 at Maia Biotechnology (MAIA)Dec 23, 2025
The full history of Stan Smith, Director is on the profile page.
How this filing works
Explore the data
Common questions
Which Maia Biotechnology (MAIA) insider traded, and how much?
Stan Smith, Director at Maia Biotechnology, bought ~$16K of Maia Biotechnology shares. 15K shares at $1.04, open market.
When did it happen, and when was it made public?
Traded: Nov 26, 2025. Filed: Dec 1, 2025. That is 5 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Maia Biotechnology recently?
For Maia Biotechnology, OQRO holds 7 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the MAIA page.
Does this mean MAIA stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Maia Biotechnology
- SEC Form 4Sep 15, 2026
- SEC Form 4Sep 14, 2026
- SEC Form 4Sep 2, 2026
- SEC Form 4Sep 2, 2026
- SEC Form 4Sep 2, 2026
- SEC Form 4Aug 26, 2026
Everything OQRO holds on this company is on its MAIA page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
